✦ LIBER ✦
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors
✍ Scribed by Anna C. Pavlick; Jennifer Wu; John Roberts; Mark A. Rosenthal; Anne Hamilton; Scott Wadler; Kathleen Farrell; Michelle Carr; David Fry; Anthony J. Murgo; Ruth Oratz; Howard Hochster; Leonard Liebes; Franco Muggia
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 335 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.